Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History PMVP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics PMVP

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Pmv Pharmaceuticals Inc

PMVP
Current price
1.26 USD -0.017 USD (-1.32%)
Last closed 1.27 USD
ISIN US69353Y1038
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 65 979 928 USD
Yield for 12 month -20.25 %
1Y
3Y
5Y
10Y
15Y
PMVP
21.11.2021 - 28.11.2021

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey. Address: 400 Alexander Park Drive, Princeton, NJ, United States, 08540

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8.75 USD

P/E Ratio

Dividend Yield

Financials PMVP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures PMVP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-1 257 000 USD

Current Quarter

Last Quarter

EBITDA -87 975 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -27.24 %
PEG Ratio
Return On Equity TTM -32.66 %
Wall Street Target Price 8.75 USD
Revenue TTM
Book Value 3.08 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.18 USD
Diluted Eps TTM -1.18 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation PMVP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 1.24
Price Book MRQ 0.42

Technical Indicators PMVP

For 52 Weeks

0.81 USD 1.82 USD
50 Day MA 1.01 USD
Shares Short Prior Month 868 726
200 Day MA 1.31 USD
Short Ratio 2.52
Shares Short 937 875
Short Percent 1.98 %